Commercialization: Page
-
PharmaVoice Team/PharmaVoice
Making Pharma Websites More Effective by Addressing User Experience
Avenue-e Health Strategies Making Pharma Websites More Effective by Addressing User Experience William Martino Manager, User Experience Group, Avenue-e Health Strategies, an S&H Company In today’s healthcare environment, it is becoming more important that the pharmaceutical ind...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Solutions Gain Momentum
E-Solutions Gain Momentum by Taren Grom and Denise Myshko The Forum Life-sciences executives recognize the benefits of e-solutions — from ROI to increased audience reach to reduced paper files — which are a common part of many programs, whether for R&D, marketing, salesforces...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Accurately Costing a Clinical Trial
Accurately Costing a Clinical Trial By Denise Myshko Streamlining the budget process not only leads to more accurate resource allocation, it also allows for better predictions and creates more accurate clinical-trial planning. July 2003 Clinical-trial spending has increased considerably over the ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
E-Media July 2005 StayinFront Introduces Data Quality Services Offerings StayinFront Inc. has enhanced its Visual Elk customer relationship management (CRM) solution with the addition of Data Quality Services, which provides customers with a turnkey solution to improve, standardize, augment, and ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive Appointments and Promotions in the Healthcare Industry October 2003 Pharma POOL Dr. Alan Breier Dr. Michael Clayman Dr. Tim Franson Lilly Announces Personnel Changes Eli Lilly recently announced personnel changes. Alan Breier, M.D., has been promoted to the role of VP for medical and ch...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Behind the Closed Door
October 2003 Behind the Closed Door By Elisabeth Pena blank canvas … or marketing opportunity? The exam room is an ideal frontier for pharmaceutical marketing messages. Companies that develop desk-top anatomical models, wall charts and graphs, and exam-table paper are gaining access to the inner ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Outsourcing: A Vital Clinical Strategy
Outsourcing: A Vital Clinical Strategy A large, unmet need exists for improved research and development productivity within pharmaceutical and biotechnology companies. Outsourcing discovery research, clinical trials, and formulation manufacturing ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Michael J. DuBois Jeffrey A. Winton Schering-Plough Announces VP Appointments Schering-Plough, Kenilworth, N.J., has appointed Michael J. DuBois senior VP of global licensing. In this role, Mr. DuBois, 56, is responsible for the acquisition of new products discovered outside Schering-...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Continuing Evolution of EDC
Paper may still reign supreme, but the EDC industry is coming of age. There is widespread agreement — at least intuitively — that the use of an electronic device or software application that allows direct data entry into electronic format has the potential to reduce time and money within the drug...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Flying High On A Vision
Flying High on a Vision By Kim Ribbink Entrepreneurs are individuals who make innovation possible; they are the people who stake their reputation, finances, and future on running their own businesses and achieving something different. As pharmaceutical and service companies continue to merge, bus...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Jean-Louis Anspach Michael R. Dornhecker Ann Willmoth Solvay Pharmaceuticals Announces Key Promotions Solvay Pharmaceuticals, Marietta, Ga., has named Jean-Louis Anspach as VP, commercial operations, responsible for managing all aspects of the primary-care business unit, including sal...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Ideology Vs. Science: The Stem-Cell Battle
Ideology Vs. Science: The Stem-Cell Battle By Kim Ribbink Across the globe, scientists are extolling the potential of stem- cell research to cure debilitating diseases, in spite of limits on federal funding as well as controversy surrounding the research. States and private investors have begun t...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DTC: The Next Phase
In light of FDA guidances, more public scrutiny, and trending corporate citizenship, DTC advertising is subtly shifting to direct-to-education. Direct-to-consumer advertising has been mainly focused on creating brand awareness for major blockbuster products, or creating awareness for new therapeu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Integration Architects: The Bridge to Peak Technological Solutions
Integration Architects: The Bridge to Peak Technological Solutions One critical and often overlooked member of the core project team is the integration architect, who defines and translates key information across technology applications. Yet many organizations do not explicitly define these posit...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Letters Informative DTC ads still have a long way to go. Hold the dogs, skateboards, straw hats, happy motorcycling couples, and all those grandkids. — Carol Bohach, B.S.Pharm. Clinical Research Consultant November 2003 Advertising and patient education need to join hands Back in the 1980s, I wro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, marketing, And R&D Trends affecting the healthcare industry Rising Drug Expenditures Spur Rx-to-OTC Switches Rising prescription drug spending in both the United States and Europe is prompting an increase in the change of drugs from prescription to over-the-counter (OTC) st...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
GSW Opens New York Office New location solidifies inChord’s presence in the Northeast pharmaceutical corridor and facilitates interaction between other East Coast corporate entities. Gerbig, Snell/Weisheimer (GSW) has recently expanded its operations by opening an office in New York. The new offi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover The time for transparency The government, medical journal editors, and general public are clamoring for the pharmaceutical industry to provide complete information about ongoing and completed clinical trials. There has been a flurry of activity, announcements, and mandates in this ar...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
Clinical-Trial Transparency: The Pros and Cons Representing Biotech with David King DTC: The Next Evolution PharmaVOICE www.pharmavoice.com June 2005 Volume 5, Number 6 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single branding elements. Cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
CME Programs Accredited by Universities and Societies Receive Preference Continuing medical education (CME) programs created by medical communications agencies achieve a higher level of acceptance among physicians when they are accredited through partnerships with respected university medical sch...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Risk Aversion As a Profitability-Limiting Factor in Clinical-Trial Conduct
Risk Aversion As a Profitability-Limiting Factor in Clinical-Trial Conduct What is risk? Why does it matter? Shouldn’t prudent business people try to avoid it? How does it impact the conduct of clinical trials, and can it or should it change? Timothy Pratt, Ph.D., Chief marketing officer of MedNe...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Jim Montgomery Building Effective Communications For the Life-Sciences Marketplace Open the latest issue of Science or Biotechniques, and browse through the ads. But be forewarned; it’s not pretty. First, there are the companies that clearly aspire to be marketers, all of them stru...
By Jim Montgomery • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Colin J. Foster In the Aftermath of September 11, U.S. Security is A New Reason to Improve Science Education Innovations in science and technology have long been synonymous with economic prosperity. On the other hand, it’s probably safe to say that science and technology and the st...
By Colin J. Foster • Jan. 2, 2008
Previous
